FDA Inspection 1256422 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 3003506975

The FDA completed an inspection of American Red Cross Blood Services on December 3, 2024 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 3, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Atlanta, GA (United States)